The novel mineralocorticoid receptor antagonist finerenone attenuates neointima formation after vascular injury.

PLoS One · 2017 · PMC5605005 · PMID 28926607

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a clear trendno p-value reported

Whereas finerenone treatment at concentrations of 1 nM showed a clear trend towards reduced SMC proliferation rates, 10 nM finerenone sufficiently and significantly prevented aldosterone-induced SMC proliferation (* P <0.05 to serum-free, # P <0.05 to DMSO, n = 6, Fig 1A and 1B ).

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.